Different somatic mutations in multinodular adrenals with aldosterone-producing adenoma

Hypertension

Volumn 66, Issue 5, 2015, Pages 1014-1022

  Fernandes Rosa, Fabio Luiz ^a,b,c   Giscos Douriez, Isabelle ^a,b   Amar, Laurence ^a,b,c   Gomez Sanchez, Celso E ^d   Meatchi, Tchao ^a,b,c   Boulkroun, Sheerazed ^a,b   Zennaro, Maria Christina ^a,b,c  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

adrenal cortex; aldosterone; hyperaldosteronism; mineralocorticoids; mutation; potassium channels

Indexed keywords

ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.3; KCNJ5 PROTEIN; POTASSIUM CHANNEL; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 2B3; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ATP1A1 PROTEIN, HUMAN; ATP2B3 PROTEIN, HUMAN; CACNA1D PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADRENAL GLAND; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SOMATIC MUTATION; ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ALLELE; COHORT ANALYSIS; COMPARATIVE STUDY; GENETICS; HYPERALDOSTERONISM; METABOLISM; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ALLELES; CALCIUM CHANNELS, L-TYPE; COHORT STUDIES; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENOTYPE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; RETROSPECTIVE STUDIES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84943374783     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05993     Document Type: Article

References (27)

1. Rossi GP, Bernini G, Caliumi C, PAPY Study Investigators A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 48 2293 2300. doi: 10.1016/j.jacc.2006.07.059
2. Hannemann A, Bidlingmaier M, Friedrich N, Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol 2012 167 7 15. doi: 10.1530/EJE-11-1013
3. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr., Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004 89 1045 1050. doi: 10.1210/jc.2003-031337
4. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003 348 1309 1321. doi: 10.1056/NEJMoa030207
5. Zannad F, McMurray JJ, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF Study Group Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011 364 11 21. doi: 10.1056/NEJMoa1009492
6. Savard S, Amar L, Plouin PF, Steichen O., Cardiovascular complications associated with primary aldosteronism: A controlled cross-sectional study. Hypertension 2013 62 331 336. doi: 10.1161/HYPERTENSIONAHA.113.01060
7. Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F., Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 2013 98 4826 4833. doi: 10.1210/jc.2013-2805
8. Amar L, Plouin PF, Steichen O., Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010 5 9. doi: 10.1186/1750-1172-5-9
9. Azizan EA, Poulsen H, Tuluc P, Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 2013 45 1055 1060. doi: 10.1038/ng.2716
10. Scholl UI, Goh G, Stölting G, Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 2013 45 1050 1054. doi: 10.1038/ng.2695
11. Beuschlein F, Boulkroun S, Osswald A, Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 2013 45 440 4, 444e1. doi: 10.1038/ng.2550
12. Choi M, Scholl UI, Yue P, K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011 331 768 772. doi: 10.1126/science.1198785
13. Fernandes-Rosa FL, Williams TA, Riester A, Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 2014 64 354 361. doi: 10.1161/HYPERTENSIONAHA.114.03419
14. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE., Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 2012 153 1774 1782. doi: 10.1210/en.2011-1733
15. Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP., Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A 2012 109 2533 2538. doi: 10.1073/pnas.1121407109
16. Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L, Plouin PF, Lalli E, Jeunemaitre X, Benecke A, Meatchi T, Zennaro MC., Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 2010 56 885 892. doi: 10.1161/HYPERTENSIONAHA.110.158543
17. Boulkroun S, Beuschlein F, Rossi GP, Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012 59 592 598. doi: 10.1161/HYPERTENSIONAHA.111.186478
18. Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B., Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab 2014 99 E1341 E1351. doi: 10.1210/jc.2013-4255
19. Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T, Ogishima T, Suematsu M, Mukai K., Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab 2010 95 2296 2305. doi: 10.1210/jc.2009-2010
20. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, Endocrine Society Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008 93 3266 3281. doi: 10.1210/jc.2008-0104
21. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin PF., Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008 26 1816 1823. doi: 10.1097/HJH.0b013e3283060f0c.
22. Boulkroun S, Samson-Couterie B, Golib-Dzib JF, Amar L, Plouin PF, Sibony M, Lefebvre H, Louiset E, Jeunemaitre X, Meatchi T, Benecke A, Lalli E, Zennaro MC., Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology 2011 152 4753 4763. doi: 10.1210/en.2011-1205
23. Wolkersdörfer GW, Bornstein SR., Tissue remodelling in the adrenal gland. Biochem Pharmacol 1998 56 163 171
24. Sasano H, Suzuki T, Moriya T., Lloyd RV, Adrenal cortex. Endocrine Pathology: Differential Diagnosis and Molecular Advances 2003 Totowa, NJ Humana Press 211 226
25. Zilbermint M, Xekouki P, Faucz FR, Primary aldosteronism and ARMC5 variants. J Clin Endocrinol Metab 2015 100 E900 E909. doi: 10.1210/jc.2014-4167
26. Assié G, Libé R, Espiard S, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. N Engl J Med 2013 369 2105 2114. doi: 10.1056/NEJMoa1304603
27. Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM., Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 2012 59 587 591. doi: 10.1161/HYPERTENSIONAHA.111.186239